One thing to look at especially when it comes to penny stocks is volume. If you look at this chart, OVID stock is holding above the previous gap zone. However, volume has consistently deteriorated. My question is can this sustain levels above the gap zone or are we looking at a further pullback?
"Since June, shares of this biotechnology penny stock rallied from lows of $1.53 to highs of $3.97 late last month. However, on Friday, the stock tanked 27% after announcing a public offering to raise money for the company.Even so, the proceeds of the gross $32.5 million will be put to immediate use. Proceeds from the Offerings will be used “primarily to advance the clinical development of its OV101 and OV935 programs.” The remainder will be for working capital and general corporate purposes."*
About OVID
Ovid Therapeutics Inc is a US based biopharmaceutical company. The firm is engaged primarily in developing impactful medicines for patients and families living who are suffering with rare neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life.
*Quote Source: 3 Penny Stocks To Watch After Latest Biotech News
"Since June, shares of this biotechnology penny stock rallied from lows of $1.53 to highs of $3.97 late last month. However, on Friday, the stock tanked 27% after announcing a public offering to raise money for the company.Even so, the proceeds of the gross $32.5 million will be put to immediate use. Proceeds from the Offerings will be used “primarily to advance the clinical development of its OV101 and OV935 programs.” The remainder will be for working capital and general corporate purposes."*
About OVID
Ovid Therapeutics Inc is a US based biopharmaceutical company. The firm is engaged primarily in developing impactful medicines for patients and families living who are suffering with rare neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life.
*Quote Source: 3 Penny Stocks To Watch After Latest Biotech News